Functional imaging as a window to dementia: Corticobasal degeneration

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 16, Issue 4, 2004, Pages 393-399

  Seritan, Andreea L ^a   Mendez, Mario F ^b   Silverman, Daniel H S ^b   Hurley, Robin A ^c,d,e   Taber, Katherine H ^c,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f University of Texas School of Health Information Sciences at Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGITATION; ANXIETY; APATHY; APRAXIA; ARTICLE; ASTROCYTE; BASAL GANGLION; BRAIN BLOOD FLOW; CLINICAL FEATURE; COMPARATIVE STUDY; CORTICOBASAL DEGENERATION; DELUSION; DEMENTIA; DEPRESSION; DOPAMINERGIC SYSTEM; HUMAN; IRRITABILITY; MEMORY DISORDER; METABOLISM; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSESSIVE COMPULSIVE DISORDER; OCCIPITAL LOBE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SENSORY DYSFUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA; THALAMUS;

EID: 10644230052     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.16.4.393     Document Type: Article

References (46)

1. Wenning GK, Litvan I, Jankovic J, et al: Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64:184-189
2. Mendez MF, Cummings JL: Dementia. A Clinical Approach, 3rd ed. Philadelphia, Butterworth Heinemann, 2003
3. Cummings JL: The Neuropsychiatry of Alzheimer's Disease and Related Dementias. London, Martin Dunitz, 2003
4. Soliveri P, Monza D, Paridi D, et al: Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999; 53:502-507
5. Frasson E, Moretto G, Beltramello A, et al: Neuropsychological and neuroimaging correlates in corticobasal degeneration. Ital J Neurol Sci 1998; 19:321-328
6. Grimes DA, Lang AE, Bergeron CB: Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999; 53:1969-1974
7. Rebeiz JJ, Kolodny EH, Richardson EP Jr: Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968; 18:20-33
8. Boeve BF, Lang A, Litvan I: Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003; 54(suppl 5):S15-S19
9. Volicer L, McKee A, Hewitt S: Dementia. Neurol Clin 2001; 19:867-885
10. DePold Hohler A, Ransom BR, Chun MR, et al: The youngest reported case of corticobasal ganglia degeneration. Parkinsonism Relat Disord 2003; 10:47-50
11. Litvan I, Agid Y, Goetz C, et al: Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48:119-125
12. Cummings JL, Litvan I: Neuropsychiatric aspects of corticobasal degeneration. Adv Neurol 2000; 82:147-152
13. Litvan I, Cummings JL, Mega M: Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 1998; 65:717-721
14. Kertesz A, Martinez-Lage P, Davidson W, et al: The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000; 55:1368-1375
15. Graham NL, Bak TH, Hodges JR: Corticobasal degeneration as a cognitive disorder. Mov Disord 2003; 18:1224-1232
16. Hanna R Doody R: Alien limb sign. Adv Neurol 2000; 82:135-145
17. Mendez MF: Corticobasal ganglionic degeneration with Balint's syndrome. J Neuropsychiatry Clin Neurosci 2000; 12:273-275
18. Monza D, Ciano C, Scaioli V, et al: Neurophysiological features in relation to clinical signs in clinically diagnosed corticobasal degeneration. Neurol Sci 2003; 24:16-23
19. Savoiardo M, Grisoli M, Girotti F: Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias. Adv Neurol 2000; 82:197-208
20. Ikeda K, Iwasaki Y, Ichikawa Y: Cognitive and MRI aspects of corticobasal degeneration and progressive supranuclear palsy (letter). Neurology 2000; 54:1878
21. Groschel K, Hauser TK, Luft A, et al: Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 2004; 21:714-724
22. Moretti R, Ukmar M, Torre P, et al: Cortico-basal ganglionic degeneration: a clinical, functional and cognitive evaluation (1-year follow-up). J Neurol Sci 2000; 182:29-35
23. Ukmar M, Moretti R, Torre P, et al: Corticobasal degeneration: structural and functional MRI and single-photon emission computed tomography. Neuroradiology 2003; 45:708-712
24. Yamauchi H, Fukuyama H, Nagahama Y, et al: Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration. Arch Neurol 1998; 55:609-614
25. Wolters A, Classen J, Kunesch E, et al: Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes. Mov Disord 2004; 19:518-528
26. Trompetto C, Buccolieri A, Marchese R, et al: Impairment of transcallosal inhibition in patients with corticobasal degeneration. Clin Neurophysiol 2003; 114:2181-2187
27. Hosaka K, Ishii K, Sakamoto S, et al: Voxel-based comparison of regional cerebral metabolism between PSP and corticobasal degeneration. J Neurol Sci 2002; 199:67-71
28. Ishii K: Clinical application of PET for diagnosis of dementia. Ann Nucl Med 2002; 16:515-525
29. Taniwaki T, Yamada T, Yoshida T, et al: Heterogeneity of glucose metabolism in corticobasal degeneration. J Neurol Sci 1998; 161:70-76
30. Hirono N, Ishii K, Sasaki M, et al: Features of regional cerebral glucose metabolism abnormality in corticobasal degeneration. Dement Geriatr Cogn Disord 2000; 11:139-146
31. Lutte I, Laterre C, Bodart JM, et al: Contribution of PET studies in diagnosis of corticobasal degeneration. Eur Neurol 2000; 44:12-21
32. Garraux G, Salmon E, Peigneux P, et al: Voxel-based distribution of metabolic impairment in corticobasal degeneration. Mov Disord 2000; 15:894-904
33. Laureys S, Salmon E, Garraux G, et al: Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. J Neurol 1999; 246:1151-1158
34. Nagasawa H, Tanji H, Nomura H, et al: PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal ganglia degeneration. J Neurol Sci 1996; 139:210-217
35. Frisoni GB, Pizzolato G, Zanetti O, et al: Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis. Eur Neurol 1995; 35:50-54
36. Hossain AK, Murata Y, Zhang L, et al: Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping. Mov Disord 2003; 18:697-703
37. Zhang L, Murata Y, Ishida R, et al: Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET. Nucl Med Commun 2001; 22:767-772
38. Okuda B, Tachibana H, Kawabata K, et al: Comparison of brain perfusion in corticobasal degeneration and Alzheimer's disease. Dement Geriatr Cogn Disord 2001; 12:226-231
39. Okuda B, Tachibana H, Kawabata K, et al: Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. Alzheimer Dis Assoc Disord 2000; 14:46-52
40. Okuda B, Tachibana H, Kawabata K, et al: Cerebral blood flow correlates of higher brain dysfunctions in corticobasal degeneration. J Geriatr Psychiatry Neurol 1999; 12:189-193
41. 123I]β-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord 2000; 15:1158-1167
42. 99mTc]TRODAT-1 SPET. Nucl Med Commun 2004; 25:339-345
43. Tedeschi G, Litvan I, Bonavita S, et al: Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 1997; 120:1541-1552
44. Abe K, Terakawa H, Takanashi M, et al: Proton magnetic resonance spectroscopy of patients with parkinsonism. Brain Res Bull 2000; 52:589-595
45. Kizu O, Yamada K, Nishimura T: Proton chemical shift imaging in Pick complex. Am J Neuroradiol 2002; 23:1387-1392
46. Coulier IM, de Vries JJ, Leenders KL: Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglia degeneration? Mov Disord 2003; 18:1175-1178